Keyword

aprocitentan

Description: Aprocitentan is a dual endothelin receptor antagonist medication studied and used to treat hypertension, including resistant hypertension.
Wikidata ID: wiki/Q27146161
OpenAlex ID: keywords/aprocitentan
2023 · Panagiotis I Georgianos, Rajiv Agarwal · Nephrology Dialysis Transplantation · 117
2024 · J. David Smeijer, Donald E. Kohan, et al. · Nature Reviews Nephrology · 68
2022 · Parisa Danaietash, Pierre Verweij, et al. · Journal of Clinical Hypertension · 39
2022 · Martine Clozel · Canadian Journal of Physiology and Pharmacology · 36
2024 · Sohita Dhillon · Drugs · 33
2023 · Carmine Zoccali, Francesca Mallamaci, et al. · Clinical Kidney Journal · 32
2020 · Pierre Gueneau de Mussy, Patricia N. Sidharta, et al. · Clinical Pharmacology & Therapeutics · 30
2025 · Matthew Sayer, David J. Webb, et al. · Nature Reviews Cardiology · 29
2023 · Sayeh Heidari Nejad, Omar Azzam, et al. · Current Hypertension Reports · 25
2021 · Emily K. McCoy, Katelin M. Lisenby · Journal of Cardiovascular Pharmacology · 25
2019 · Patricia N. Sidharta, Jasper Dingemanse · European Journal of Drug Metabolism and Pharmacokinetics · 25
2018 · Michel Burnier · Current Hypertension Reports · 23
2023 · Omar Azzam, Sayeh Heidari Nejad, et al. · British Journal of Pharmacology · 22
2021 · Patricia N. Sidharta, Hartmut Fischer, et al. · Current Drug Metabolism · 22
2023 · Miguel Camafort, Reinhold Kreutz, et al. · Heart · 21
2020 · Patricia N. Sidharta, Jasper Dingemanse · Clinical Pharmacology in Drug Development · 20
Works count: 198
Citation count: 1,576
Year
Topic
Type